Statistics for Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data
Total visits
| views | |
|---|---|
| Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data | 59 |
Total visits per month
| views | |
|---|---|
| November 2023 | 0 |
| December 2023 | 0 |
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
File Visits
| views | |
|---|---|
| 12933_2021_Article_1345.pdf | 63 |
Top country views
| views | |
|---|---|
| United States | 23 |
| Ireland | 16 |
| Canada | 4 |
| Germany | 4 |
| China | 3 |
| Sweden | 3 |
| France | 2 |
| Vietnam | 2 |
| Cyprus | 1 |
| Japan | 1 |
Top city views
| views | |
|---|---|
| Dublin | 16 |
| Ashburn | 6 |
| Seattle | 5 |
| Inglewood | 3 |
| Winnipeg | 3 |
| Zhengzhou | 3 |
| Brooklyn | 2 |
| Hanoi | 2 |
| Des Moines | 1 |
| Nagold | 1 |
| Tokyo | 1 |
| Winkler | 1 |